Effect of coadministration of M-CSF and IFN-α on NK1.1+ cells in mice

Journal of Interferon and Cytokine Research

Volumn 22, Issue 6, 2002, Pages 701-708

  Sakurai, Takuma ^a   Motoyoshi, Kazuo ^a   Misawa, Eriko ^a   Tanaka Douzono, Miyuki ^a   Hagesita, Hiroaki ^a   Nomaguchi, Kouji ^a   Tetsuya, Kuhara ^a   Suzu, Shinya ^a   Yamada, Muneo ^a   Hayasawa, Hirotoshi ^a  

^a MORINAGA MILK INDUSTRY CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; RECOMBINANT ALPHA INTERFERON; RECOMBINANT COLONY STIMULATING FACTOR 1; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFECT; IN VIVO STUDY; LUNG; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MELANOMA B16; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD11C; ANTIGENS, CD3; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; INTERFERON-ALPHA; KILLER CELLS, NATURAL; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; RECOMBINANT PROTEINS; SPLEEN;

ANIMALIA;

EID: 0036376703     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/10799900260100204     Document Type: Article

References (46)

1. Biological properties of recombinant α-interferons: 40th anniversary of the discovery of interferons
2. Biologic responses to IFN-α administration in humans
3. Interferon activation and innate immunity
4. The function of type I interferons in antimicrobial immunity
5. Effects of several species of human leukocyte interferon on cytotoxic activity of NK cells and monocytes
6. Natural killer cells in antiviral defence: Function and regulation by innate cytokine
7. Structure, biosynthesis and biological roles of monocyte-macrophage colony stimulating factor (CSF-1 or M-CSF)
8. Biological activities and clinical application of M-CSF
9. Serum cholesterol-lowering activity of human monocytic colony-stimulating factor
10. Colony-stimulating factor 1 is required for mammary gland development during pregnancy
11. Protective effect of partially purified human urinary colony-stimulating factor on granulocytopenia after antitumor chemotherapy
12. Double-blind test of human urinary macrophage colony-stimulating factor for allogeneic and syngeneic bone marrow transplantation: Effectiveness of treatment and 2-year follow for relapse of leukemia
13. Long-term follow-up of patients with invasive fungal disease who received adjunctive therapy with rhM-CSF
14. Human urinary macrophage colony-stimulating factor reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: A double-blind controlled study
15. Colony-stimulating factor-induced monocyte survival and differentiation into macrophage in serum-free cultures
16. Effects of granulocyte-macrophage colony-stimulating factor and colony-stimulating factor-1 on the proliferation and differentiation of murine alveolar macrophages
17. Effects of recombinant human colony-stimulating factors (CSF) (granulocyte-macrophage CSF, granulocyte CSF, and CSF-1) on human monocyte/macrophage differentiation
18. Enhancement of the antibody-dependent tumoricidal activity of human monocytes by human monocytic colony-stimulating factor
19. Biological and antitumor effects of recombinant human macrophage colony-stimulating factor in mice
20. Selective activation-induced apoptosis of peripheral T cells imposed by macrophages
21. Therapeutic efficacy of human macrophage colony-stimulating factor, used alone and in combination with antifungal agents, in mice with systemic Candida albicans infection
22. Cooperative effects of colony-stimulating factor 1 and recombinant interleukin 2 on proliferation and induction of cytotoxicity of macrophage precursors generated from mouse bone marrow cell cultures
23. + cells in mice
24. Phase I trial of combined immunotherapy with subcutaneous granulocyte-macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma
25. Granulocyte/macrophage-colony-stimulating factor augments plus interleukin-2 plus interferon alpha in the treatment of metastatic renal cell carcinoma: A pilot study
26. Treatment of patient with low-risk myelodysplastic syndromes using a combination of all-trans retinoic acid, interferon alpha, and granulocyte colony-stimulating factor
27. Granulocyte/macrophage-colony-stimulating factor augments lymphokine-activated killer activity from lymphocytes via macrophages in lung cancer patients
28. A clinical trial of edrecolomab, interleukin-2 and GM-CSF in patients with advanced colorectal cancer
29. Sequential administration of interferon-gamma. GM-CSF, and interleukin-2 in patients with metastatic renal cell carcinoma: Results of a phase II trial
30. Enhancement of the anti-tumor activity of a peripheral blood progenitor cells graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer
31. Chemoimmunotherapy of murine solid tumors: Enhanced therapeutic effects by interleukin-2 combined with interferon alpha and the role of specific T cells
32. Combined chemoimmunotherapy in metastatic melanoma - Is there a need for the double?
33. Purification of human urinary colony-stimulating factor by high performance liquid chromatography
34. Rapid in vivo assay of mouse natural killer cell activity
35. + cell activity in vivo
36. + T cells lose NK1.1 expression upon in vitro activation
37. Type I IFNs enhance the terminal differentiation of dendritic cells
38. Low levels of interferon-alpha induce CD86 (B7.2) expression and accelerate dendritic cell maturation from human peripheral blood mononuclear cells
39. + precursors
40. Differential regulation of human blood dendritic cell subsets by IFNs
41. Lack of mda-6/WAF1/CIP1-mediated inhibition of cyclin-dependent kinases in interferon-alpha-resistant murine B16 melanoma cells
42. Interferon-alpha-induced inhibition of B16 melanoma cell proliferation: Interference with the bFGF autocrine growth circuit
43. Natural killer (NK) cells are functionally abnormal and NK cell progenitors are diminished in granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cell collections
44. Suppression of natural killer cell activity by granulocytes in patients with aplastic anemia: Role of granulocyte colony-stimulating factor
45. Suppressive effect of granulocyte-macrophage colony-stimulating factor on the generation of natural killer cells in vitro
46. Serum macrophage colony-stimulating factor (M-CSF) levels correlate with clinical response to interferon-alpha in patients with early-stage B-CLL